ANIXA BIOSCIENCES, INC. Additional Paid in Capital, Common Stock
ANIXA BIOSCIENCES, INC. (ANIX) had Additional Paid in Capital, Common Stock of $151.23 million as of 2016-01-31, per its 10-Q filed 2016-02-19.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2016-02-19
- 2016-01-31: Additional Paid in Capital, Common Stock $151.23M.
- 2015-10-31: Additional Paid in Capital, Common Stock $151.10M.
- 2014-10-31: Additional Paid in Capital, Common Stock $148.68M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2016-01-31 | $151.23M 10-Q · filed 2016-02-19 |
| 2015-10-31 | $151.10M 10-Q · filed 2016-02-19 |
| 2014-10-31 | $148.68M 10-K · filed 2015-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |